Analyst Reco. Innoviva, Inc.

Equities

INVA

US45781M1018

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-24 pm EDT			5-day change	1st Jan Change
15.78 ^USD	-0.06%		-1.25%	-1.62%

May. 20	Zai Lab, Innoviva Subsidiary Receive China Approval for Hospital Infection Treatment	MT
May. 15	Transcript : Innoviva, Inc. Presents at Bank of America Health Care Conference 2024, May-15-2024 09:20 AM

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Morgan Stanley Adjusts Price Target on Innoviva to $10 From $13, Maintains Underweight Rating	23-03-03	MT
Morgan Stanley Adjusts Price Target on Innoviva to $14 From $13, Maintains Underweight Rating	22-10-13	MT
Goldman Sachs Starts Innoviva at Neutral With $16 Price Target	22-07-20	MT
Morgan Stanley Trims Innoviva's Price Target to $12 From $13, Underweight Rating Maintained	22-07-15	MT
Morgan Stanley Raises Innoviva's Price Target to $13 From $12, Maintains Underweight Rating	22-04-12	MT
Morgan Stanley Raises Innoviva's Price Target to $12 From $10, Maintains Underweight Rating	22-02-23	MT
INNOVIVA : Morgan Stanley Adjusts Innoviva PT to $10 From $8, Maintains Underweight Rating	20-11-11	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Secure and Increase the Performance of your Investments with our Team of Experts at your Side

Securing my Investments

fermer